chartexchange

Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates

GlobeNewswire Inc. | Nov 12, 2026 4:00 PM EST

– Initiated Phase 2 clinical study of ABI-6250 in patients with chronic hepatitis delta virus infection –

Read original article